For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Receptor tyrosine-protein kinase erbB3, also known as HER3 (human epidermal growth factor receptor 3) is a membrane bound protein that is encoded by the ERBB3 gene. ErbB3 has a neuregulin binding domain, however, does not have an active kinase domain and can therefore bind this ligand but is unable to convey the signal into the cell through protein phosphorylation. ErbB3 forms heterodimers with other EGF receptor family members which have kinase activity. Heterodimerization leads to the activation of pathways that trigger cell proliferation or differentiation. ErbB3 overexpression is an indicator of poor patient prognosis in human breast cancer and has also been reported in other cancers such as prostate and bladder.
The AlphaLISA SureFire Ultra Human Total ErbB3 Detection Kit is a sandwich immunoassay for the quantitative detection of total ErbB3 in cellular lysates, using Alpha Technology.
檢測點(200-50,000) | 100 Assay Points |
---|---|
檢測目標 | ErbB3 |
檢測技術 | Alpha |
自動化兼容 | Yes |
檢測方法 | Alpha |
實驗類型 | In vitro |
產品品牌名稱 | AlphaLISA SureFire Ultra |
運輸條件 | 藍冰 |
Target Species | Human |
治療領域 | Oncology |
產品尺寸 | 100 Assay Points |
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...